A Pilot Study on the Noninvasive Evaluation of Intestinal Damage in Celiac Disease Using I-FABP and L-FABP

Journal of Clinical Gastroenterology

Volumn 43, Issue 8, 2009, Pages 727-733

  Derikx, Joep P M ^a   Vreugdenhil, Anita C E ^a   Van den Neucker, Anita M ^b   Grootjans, Joep ^b   van Bijnen, Annemarie A ^c   Damoiseaux, Jan G M C ^c   van Heurn, L W Ernest ^c   Heineman, Erik ^c   Buurman, Wim A ^c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b Department of Paediatrics ^*  (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Celiac disease; Diagnosis; Fatty acid binding protein; Follow up

Indexed keywords

EID: 67649643943     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31819194b0     Document Type: Article

References (19)

1. Chand N, Mihas AA. Celiac disease: current concepts in diagnosis and treatment. J Clin Gastroenterol. 2006;40:3-14.
2. Green PH, Cellier C. Celiac disease. N Engl J Med. 2007;357:1731-1743.
3. Hopper AD, Hadjivassiliou M, Butt S, et al. Adult coeliac disease. BMJ. 2007;335:558-562.
4. Rostom A, Dube C, Cranney A, et al. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology. 2005;128:S38-S46.
5. Pietzak MM. Follow-up of patients with celiac disease: achieving compliance with treatment. Gastroenterology. 2005;128:S135-S141.
6. Salmi TT, Collin P, Korponay-Szabo IR, et al. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits. Gut. 2006;55:1746-1753.
7. Esteve M, Rosinach M, Fernandez-Banares F, et al. Spectrum of gluten-sensitive enteropathy in first-degree relatives of patients with coeliac disease: clinical relevance of lymphocytic enteritis. Gut. 2006;55:1739-1745.
8. Sanders DS, Hurlstone DP, McAlindon ME, et al. Antibody negative coeliac disease presenting in elderly people—an easily missed diagnosis. BMJ. 2005;330:775-776.
9. Vahedi K, Mascart F, Mary JY, et al. Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease. Am J Gastroenterol. 2003;98:1079-1087.
10. Kaukinen K, Sulkanen S, Maki M, et al. IgA-class transglutaminase antibodies in evaluating the efficacy of gluten-free diet in coeliac disease. Eur J Gastroenterol Hepatol. 2002;14:311-315.
11. Dickey W, Hughes DF, McMillan SA. Disappearance of endomysial antibodies in treated celiac disease does not indicate histological recovery. Am J Gastroenterol. 2000;95:712-714.
12. Tursi A, Brandimarte G, Giorgetti GM. Lack of usefulness of anti-transglutaminase antibodies in assessing histologic recovery after gluten-free diet in celiac disease. J Clin Gastroenterol. 2003;37:387-391.
13. Kanda T, Fujii H, Tani T, et al. Intestinal fatty acid-binding protein is a useful diagnostic marker for mesenteric infarction in humans. Gastroenterology. 1996;110:339-343.
14. Derikx JP, Evennett NJ, Degraeuwe PL, et al. Urine based detection of intestinal mucosal cell damage in neonates with suspected necrotising enterocolitis. Gut. 2007;56:1473-1475.
15. Pelsers MM, Hermens WT, Glatz JF. Fatty acid-binding proteins as plasma markers of tissue injury. Clin Chim Acta. 2005;352:15-35.
16. Pelsers MM, Namiot Z, Kisielewski W, et al. Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility. Clin Biochem. 2003;36:529-535.
17. Gollin G, Marks C, Marks WH. Intestinal fatty acid binding protein in serum and urine reflects early ischemic injury to the small bowel. Surgery. 1992;113:545-551.
18. Kanda T, Nakatomi Y, Ishikawa H, et al. Intestinal fatty acid-binding protein was a sensitive marker for intestinal ischemia. Dig Dis Sci. 1992;37:1362-1367.
19. van de Poll MC, Derikx JP, Buurman WA, et al. Liver manipulation causes hepatocyte injury and precedes systemic inflammation in patients undergoing liver resection. World J Surg. 2007;31:2033-2038.